Published in Gene Therapy Weekly, August 3rd, 2006
Surplus, whose appointment is effective immediately, fills the position formerly held by Monica Tamborini, who is retiring.
"I personally want to thank Monica for the dedicated service she has provided to the company, and at the same time welcome Karen to our management team," stated Hector Gomez, MD, PhD, DNAPrint chairman and chief medical officer. Tony F. Frudakis, DNAPrint founder and chief scientific officer, stated, "Monica's retirement is a loss for DNAPrint, and we are sad to see her go. We feel fortunate to have found...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.